fasudil has been researched along with Brain Vascular Disorders in 1 studies
fasudil: intracellular calcium antagonist; structure in first source
fasudil : An isoquinoline substituted by a (1,4-diazepan-1-yl)sulfonyl group at position 5. It is a Rho-kinase inhibitor and its hydrochloride hydrate form is approved for the treatment of cerebral vasospasm and cerebral ischemia.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Treatment with fasudil at 30 or 60 mg/day was given orally for 8 weeks." | 1.29 | Evaluation of fasudil hydrochloride treatment for wandering symptoms in cerebrovascular dementia with 31P-magnetic resonance spectroscopy and Xe-computed tomography. ( Kamei, S; Oishi, M; Takasu, T, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kamei, S | 1 |
| Oishi, M | 1 |
| Takasu, T | 1 |
1 other study available for fasudil and Brain Vascular Disorders
| Article | Year |
|---|---|
Evaluation of fasudil hydrochloride treatment for wandering symptoms in cerebrovascular dementia with 31P-magnetic resonance spectroscopy and Xe-computed tomography.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Aged; Calcium Channel Blockers; Cerebrovascular Circu | 1996 |